SOAP Note Documentation for 35-Year-Old Female with Diabetes, Worsening Anxiety, and Menstrual Irregularities
Screen this patient for anxiety using a validated tool (GAD-7) immediately, as anxiety disorders in women with diabetes are highly prevalent (up to 44%) and significantly impair glycemic control, and refer to OB/GYN for menstrual irregularities that may indicate underlying endocrine pathology. 1
Subjective
Chief Complaint: Worsening anxiety interfering with daily activities, increased fatigue with excessive sleep, and irregular/heavy menstrual cycles.
History of Present Illness:
- Anxiety: Patient reports escalating anxiety symptoms that now interfere with daily functioning. Given the 40% lifetime prevalence of anxiety disorders in women and the bidirectional relationship with diabetes, this requires immediate screening 1, 2.
- Sleep disturbances: Excessive nighttime sleep plus daytime napping suggests hypersomnia, which can indicate worsening depression or metabolic derangement.
- Menstrual irregularities: Heavy, prolonged periods (menorrhagia) alternating with missed periods (oligomenorrhea) in a 35-year-old warrants evaluation for thyroid disease, polycystic ovary syndrome, or perimenopause—all of which can exacerbate anxiety symptoms 1.
- Diabetes management: Document current medications, adherence (use MMAS-8 if available), recent glucose monitoring, and A1C values.
Past Medical History: Type 2 diabetes mellitus, major depressive disorder, generalized anxiety disorder.
Medications: List all current diabetes medications, antidepressants/anxiolytics, and adherence status (critical as 40% of patients with comorbid conditions show poor adherence) 3.
Objective
Vital Signs: Blood pressure, heart rate, weight, BMI (elevated BMI predicts worse glycemic control in patients with mental health comorbidities) 4.
Physical Exam:
- General: Assess for signs of thyroid disease (goiter, tremor, skin changes)
- Mental status: Affect, mood, psychomotor activity
- Cardiovascular: Rule out tachycardia from anxiety or thyroid dysfunction
- Abdominal: Assess for organomegaly
- Pelvic exam: Defer to OB/GYN referral
Laboratory/Screening:
- GAD-7 score: Quantify anxiety severity (scores ≥10 indicate clinically significant anxiety) 1
- PHQ-9 score: Reassess depression severity (46.5% of T2DM patients have major depression) 3
- HbA1c: Essential as each additional mental health symptom predicts higher HbA1c (β = 0.267) 4
- TSH, free T4: Rule out thyroid disease as alternative cause of anxiety and menstrual irregularities 1
- CBC: Evaluate for anemia contributing to fatigue
- Lipid panel, renal function: Per diabetes comprehensive care 5
Assessment
- Generalized anxiety disorder, worsening (F41.1) - GAD-7 score documented, interfering with daily function
- Major depressive disorder, recurrent (F33.1) - PHQ-9 score documented, with hypersomnia
- Type 2 diabetes mellitus without complications (E11.9) - Document specific complications if present (E11.65 for hyperglycemia, etc.)
- Menorrhagia (N92.0) and Oligomenorrhea (N91.5) - Requires OB/GYN evaluation
- Fatigue (R53.83)
- Hypersomnia (G47.10)
Clinical Reasoning: The bidirectional relationship between T2DM and anxiety/depression is well-established through inflammatory cytokines, HPA axis activation, and behavioral mechanisms 2, 6. Patients with all three mental health symptoms (diabetes distress, depression, anxiety) show significantly worse glycemic control 4. The menstrual irregularities may represent a separate endocrine pathology (thyroid, PCOS) that could be exacerbating both metabolic and psychiatric symptoms.
Plan
Anxiety and Depression Management
Initiate or optimize SSRI/SNRI therapy immediately, as these medications improve both mental health outcomes and medication adherence in T2DM patients 1, 6. Consider:
- Sertraline 50mg daily (start) or escitalopram 10mg daily
- Cognitive behavioral therapy referral (CBT demonstrates superior effects on medication adherence and glycemic control compared to pharmacotherapy alone) 6
- Follow-up GAD-7 and PHQ-9 in 2-4 weeks
Diabetes Management
Optimize diabetes regimen following the 2022 AACE guidelines prioritizing agents that avoid hypoglycemia and weight gain 5:
- If not on metformin: Start metformin (preferred initial therapy unless contraindicated)
- If HbA1c ≥7.5% or patient has cardiovascular/renal risk: Add GLP-1 RA (e.g., semaglutide) or SGLT2i independent of glucose-lowering needs 5
- Assess medication adherence using structured tool (MMAS-8)
- Reinforce lifestyle modifications: ≥150 min/week moderate aerobic exercise, resistance training 2-3x/week, Mediterranean-style diet emphasizing vegetables, whole grains, legumes, fish 5
Menstrual Irregularities
Refer to OB/GYN for comprehensive evaluation - Document referral with diagnosis codes N92.0 and N91.5
- Urgent if: Age >35 with new-onset irregular bleeding, bleeding between periods, or postcoital bleeding
- OB/GYN will evaluate for structural causes, endocrine disorders, and anovulation
Diagnostic Workup
- Order: HbA1c, TSH, free T4, CBC, comprehensive metabolic panel, lipid panel
- Results review in 1 week
Follow-up
- Return visit in 2 weeks to review labs and reassess mental health symptoms
- Coordinate care with OB/GYN and consider endocrinology referral if diabetes control remains suboptimal despite optimization
CPT Codes
- 99214 - Established patient office visit, moderate complexity (30-39 minutes, moderate medical decision-making given multiple chronic conditions with exacerbation)
- 96127 - Brief emotional/behavioral assessment (GAD-7, PHQ-9 administration and scoring)
ICD-10 Codes
- F41.1 - Generalized anxiety disorder
- F33.1 - Major depressive disorder, recurrent, moderate
- E11.9 - Type 2 diabetes mellitus without complications (use specific code if complications present)
- N92.0 - Excessive and frequent menstruation with regular cycle (menorrhagia)
- N91.5 - Oligomenorrhea, unspecified
- R53.83 - Other fatigue
- G47.10 - Hypersomnia, unspecified
Critical Pitfall: Do not attribute all symptoms to psychiatric illness without ruling out thyroid disease, which can mimic anxiety/depression and cause menstrual irregularities. The combination of anxiety, fatigue, and menstrual changes in a woman of reproductive age mandates thyroid screening 1.